Moreover, INCAGN01949, a fully human IgG1κ anti-OX40 agonist monoclonal antibody, was designed to promote tumor immunity by Teff activation and Fcγ receptor-mediated Treg depletion. The gene discussed is TNFRSF4; the disease is neoplasm.